Biofuels company Cellufuel's demonstration plant in Brooklyn, Nova Scotia, expected to start up in February after company receives C$1.5M provincial loan; facility will convert wood into biofuel, consume about 6,000 tonnes of fiber/year

LOS ANGELES , September 5, 2013 () – Nova Scotia-based Biofuels company Cellufuel Inc. is planning to start up its C$4 million demonstration project in Brooklyn, Canada, in February after receiving a C$1.5 million provincial loan, The Chronicle Herald reported on Aug. 30.

Nova Scotia also gave Cellufuel $500,000 in December to help with startup costs.

Private investors supplied the remaining $2.5 million in funding for the project, said Cellufuel President Chris Hooper.

The biofuels demonstration is located at the former Bowater mill site and is part of the new Innovacorp Demonstration Centre, which will focus on bioenergy and forestry innovation.

Cellufuel’s demonstration project , which will convert wood into biofuel, is expected to consume roughly 6,000 green tonnes of fiber per year during the demonstration phase.

After the company begins commercial operations, the Brooklyn project will transition into a research and development facility, said Hopper.

The company is aiming to commercialize its licensed technology over the next five or six years and launch new 10 plants.

Meteghan, Nova Scotia is being considered as a possible site for a $40 million commercial plant with a capacity of 20 million liters per year. The company has already begun planning work on the facility, which could start up by late 2014 or early 2015.

The goal is for Cellufuel to produce 200 million liters of fuel and $200 million in revenue per year, according to The Chronicle Herald’s report.

The primary source of this article is The Chronicle Herald, Halifax, Nova Scotia, on Aug. 30, 2013.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.